Clin Assess
For more than 22 years, Clin Assess is a CRO that pursue its work with great passion. They work on commercial studies including those with a high patient number.
Customers appreciate their medical background, their expertise, and the precision in which they achieve their goals and realise all phases of the clinical trial with pinpoint accuracy.
They rely on clear project communication with interactive feedback, provide individual support for their customers and accompany them step by step from the beginning and through all stages of the project.
Their employees are specialists from the pharmaceutical industry, contract research and the clinical sector. They have special expertise in the fields of oncology, cardiovascular diseases, infectious diseases, immunotherapy, personalised medicine and diseases of the central nervous system.
Learn more: www.clinassess.de
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
2 million +
patients
in database
50 000 +
users
worlwide
LATEST NEWSOUR NEWS >
November 30, 2023
📅 5th December – 1:30pm to 2:15pm (CET) 📍 On line via Gotowebinar 💶 Free but mandatory registration Register In Clinical Research, difficulties in recruiting subjects are one of the main causes of premature termination of clinical trials. Between 20 to 30% of clinical trials are affected by inclusion delays and more than 1 out of […]
November 30, 2023
Applied Clinical Trials Online Site and project management teams play major roles in risk-management and monitoring performance. As the modernization of clinical research through digital and decentralized solutions continues to take research into local communities, reduce patient and site burden, and increase diversity, it will lead to new ways of working for project delivery teams. […]
November 30, 2023
Applied Clinical Trials Online Study aims to find ways industry gets involved in the most influential clinical trials, and how transparent these trials are. In a study published earlier this month by JAMA, the authors aimed to discover how the pharmaceutical industry gets involved in the most influential modern clinical trials and how they fare […]